Subsidies kick in for liquid-based cytology

Liquid-based cytology will be added to the MBS from Monday 1 May in response to the delays in rolling out the new HPV-based national cervical screening program.

Under interim arrangements that apply until the rollout of the new program in December, a Medicare rebate of $36 will be available for liquid-based cytology tests such as ThinPrep and SurePath, in addition to the rebate for the conventional cytology test.

However, the rebate is only payable for one cervical screening test, either the liquid-based cytology test or a conventional cytology test, the Royal Australian and New Zealand